AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2010
Jan 8, 2010
35124_dirs_2010-01-08_f46030d6-93e2-466d-b3d4-20256f8184b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Celsion CORP (clsn)
CIK: 0000749647
Period of Report: 2010-01-06
Reporting Person: Tumminello Timothy J (Interim Chief Accnt Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option | $3.39 | 2019-04-13 | Celsion Corporation Common Stock (10000) | Direct | |
| Restricted Stock Agreement | $0 | Celsion Corporation Common Stock (2100) | Direct | ||
| Stock Option | $ | Celsion Corporation Common Stock (5000) | Direct |
Footnotes
F1: Vesting 2,500 each on April 13, 2010, 2011, 2012 and 2013.
F2: Vesting 700 each on April 13, 2010, 2011 and 2012. Shares of Celsion Common Stock are issued on each Vesting Date.
F3: On January 6, 2010, 5,000 options were granted subject to ratification by Celsion Corporation's Board of Directors at an exercise price to be determined on that date and vesting one third on each of the first, second and third anniversaries of employment.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18